Compounds > fleroxacin
Page last updated: 2024-10-27

fleroxacin and Actinic Reticuloid Syndrome

fleroxacin has been researched along with Actinic Reticuloid Syndrome in 2 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, M1
Kawada, A1
Kobayashi, T1
Hiruma, M1
Ishibashi, A1
Bowie, WR1
Willetts, V1
Jewesson, PJ1

Trials

1 trial available for fleroxacin and Actinic Reticuloid Syndrome

ArticleYear
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Interaction

1989

Other Studies

1 other study available for fleroxacin and Actinic Reticuloid Syndrome

ArticleYear
Photosensitivity induced by fleroxacin.
    Clinical and experimental dermatology, 1996, Volume: 21, Issue:1

    Topics: Aged; Anti-Infective Agents; Fleroxacin; Humans; Male; Photosensitivity Disorders

1996